Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir

BACKGROUND: The role of the antiviral therapy in treatment of COVID-19 is still a matter to be investigated. Also efficacy and safety of antiviral regimens were not compared according severity of the disease. In this study the efficacy and safety of hydroxychloroquine plus atazanavir/ritonavir was c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Daru
Autori principali: Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Nabiee, Morteza, Sadeghi, Setayesh, Khalili, Hossein, Abbasian, Ladan, Ghiasvand, Fereshteh, Seifi, Arash, Hasannezhad, Malihe, Ghaderkhani, Sara, Mohammadi, Mostafa, Yekaninejad, Mir Saeed
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453126/
https://ncbi.nlm.nih.gov/pubmed/32857301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40199-020-00369-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi